Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study
Mora-Ortiz M, Alcala-Diaz JF, Rangel-Zuñiga OA, et al.
BMC Med. 2022;20(1):37.
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Mora-Ortiz M, Alcala-Diaz JF, Rangel-Zuñiga OA, et al.
BMC Med. 2022;20(1):37.
Leggi
Stephan P, Eichenlaub M, Waldenmaier V, et al.
Diabetes Technol Ther. Pub. online 28 Oct 2022.
Leggi
Htoo PT, Tesfaye H, Schneeweiss S, et al.
JAMA Netw Open. 2022;5(10):e2237606.
Leggi
Biegus J, Voors AA, Collins SP, et al.
Eur Heart J. 2022;ehac530.
Leggi
Butt JH, Jhund PS, Belohlávek J, et al.
Circulation. 2022;146(16):1210-1224.
Leggi
Okoroike H, Patel S, Simone P, et al.
The American Journal of Cardiology. Pub. online 22 Oct 2022.
Leggi
Volke V, Katus U, Johannson A, et al.
BMC Endocr Disord. 2022;22(1):251.
Leggi
Ke C, Lipscombe LL, Weisman A, et al.
JAMA. Pub. online 14 Oct 2022.
Leggi
Boje AS, Sørensen MH, Gæde P, Madsen PL
Diabetes Care. 2022;dc220942.
Leggi
Lin T, Manfredo JA, Illesca N, et al.
Diabetes Technol Ther. Pub. online 12 Oct 2022.
Leggi